- ISIN
- US65344E1073
- CUSIP
- 65344E107
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- IPO Date
- Dec 22, 2021
Highlights
- Market Cap
- $4.80M
- Enterprise Value
- $7.84M
- EPS (TTM)
- -$0.38
- Total Revenue (TTM)
- $11.42M
- Gross Profit (TTM)
- $4.51M
- EBITDA (TTM)
- -$3.35M
- Year Range
- $0.48 - $2.89
- ROA (TTM)
- -28.68%
- ROE (TTM)
- -67.28%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
NXGL Performance Chart
NEXGEL, Inc. (NXGL) is down 62.1% since the beginning of the year. At $1 per share, NXGL is trading 78.9% below its 52-week high of $3.
Loading charts...
Returns By Period
NEXGEL, Inc. (NXGL) has returned -62.07% so far this year and -74.12% over the past 12 months.
NEXGEL, Inc.
- 1D
- 7.90%
- 1M
- 13.09%
- YTD
- -62.07%
- 6M
- -61.10%
- 1Y
- -74.12%
- 3Y*
- -38.77%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
NXGL Monthly Returns History
Based on dividend-adjusted daily data since Dec 22, 2021, NXGL's average daily return is -0.04%, while the average monthly return is -1.90%.
Historically, 47% of months were positive and 53% were negative. The best month was May 2023 with a return of +50.6%, while the worst month was Mar 2026 at -45.0%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.
On a daily basis, NXGL closed higher 43% of trading days. The best single day was Dec 7, 2022 with a return of +28.3%, while the worst single day was Dec 22, 2021 at -20.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -11.80% | -19.01% | -44.96% | -6.76% | 1.68% | 1.77% | -62.07% | ||||||
| 2025 | -14.35% | -18.85% | -3.87% | -12.42% | -16.86% | 18.89% | -12.80% | 9.12% | -0.61% | 0.82% | -26.83% | -10.56% | -63.90% |
| 2024 | 2.82% | 10.50% | 12.81% | -22.34% | -1.89% | 3.85% | 45.37% | -7.96% | -10.73% | 11.63% | 10.42% | 40.25% | 109.39% |
| 2023 | 12.80% | 1.06% | -10.18% | 21.88% | 50.63% | 6.45% | -6.06% | 5.11% | -14.17% | -16.04% | 6.18% | 12.70% | 70.40% |
| 2022 | 1.84% | -27.77% | 0.52% | -17.62% | -8.81% | 17.24% | 8.82% | -1.08% | -17.49% | -10.60% | -13.33% | 6.84% | -52.11% |
| 2021 | -40.68% | -40.68% |
Benchmark Metrics
NEXGEL, Inc. has an annualized alpha of -17.90%, beta of 0.76, and R2 of 0.03 versus S&P 500 Index. Calculated based on daily prices since December 22, 2021.
- This stock participated in 173.70% of S&P 500 Index downside but only -8.41% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.03 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -17.90%
- Beta
- 0.76
- R²
- 0.03
- Upside Capture
- -8.41%
- Downside Capture
- 173.70%
Return for Risk
Risk / Return Rank
NXGL ranks 7 for risk / return — in the bottom 7% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for NEXGEL, Inc. (NXGL) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NXGL | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.81 | ||
| Sortino ratioReturn per unit of downside risk | -4.24 | ||
| Omega ratioGain probability vs. loss probability | 0.84 | 1.37 | -0.53 |
| Calmar ratioReturn relative to maximum drawdown | -0.91 | 2.78 | -3.69 |
| Martin ratioReturn relative to average drawdown | -1.51 | 12.44 | -13.94 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the NEXGEL, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the NEXGEL, Inc. was 89.66%, occurring on May 15, 2026. The portfolio has not yet recovered.
The current NEXGEL, Inc. drawdown is 87.61%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -89.66%May 2026 | 1y 4mo | — | 1y 6moDec 2024 - now |
Bear market2022 | -73.43%Nov 2022 | 11mo 12d | 2y 14d | 2y 11moDec 2021 - Dec 2024 |
Drawdown Indicators
| NXGL | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.66% | -56.78% | -32.88% |
Max Drawdown (1Y)Largest decline over 1 year | -81.65% | -9.10% | -72.55% |
Max Drawdown (3Y)Largest decline over 3 years | -89.66% | -18.90% | -70.76% |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -87.61% | -1.80% | -85.81% |
Average DrawdownAverage peak-to-trough decline | -54.39% | -10.71% | -43.68% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 49.23% | 2.03% | +47.20% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of NEXGEL, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how NEXGEL, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for NXGL relative to other companies in the Medical Instruments & Supplies industry. Currently, NXGL has a P/S ratio of 0.4. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for NXGL in comparison with other companies in the Medical Instruments & Supplies industry. Currently, NXGL has a P/B value of 1.1. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with NXGL
Add NEXGEL, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with NXGL